How many patents does
Takeda Vaccines have?
patents
529
families
36
granted
96
applications
433
US
88
EP
63
JP
43
WO
36
KR
31
CN
27
RoW
241
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Takeda Vaccines
Top ten assignees appearing on patents
2009 - 2018
| takeda vaccines | 261 |
| ligocyte pharmaceuticals | 92 |
| inviragen | 82 |
| takeda vaccines (montana) | 11 |
| takeda pharmaceutical company | 2 |
| takeda vaccine | 2 |
| ligocyte pharmaceutical | 1 |
2009
| ligocyte pharmaceuticals | 8 |
| inviragen | 3 |
Takeda Vaccines
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| methods and compositions for live attenuated viruses | 47 | 2007 |
| parenteral norovirus vaccine formulations | 47 | 2011 |
| norovirus vaccine formulations | 46 | 2006 |
| compositions, methods and uses for inducing viral growth | 37 | 2008 |
| compositions and methods for administration of vaccines against dengue virus | 30 | 2009 |
| virus-like particles comprising composite capsid amino acid sequences for enhanced cross… 🛈 | 28 | 2008 |
| method of conferring a protective immune response to norovirus | 25 | 2007 |
| compositions and methods for live, attenuated alphavirus formulations | 23 | 2013 |
| compositions and methods for dengue virus chimeric constructs in vaccines | 23 | 2013 |
| virus like particle purification | 22 | 2007 |